Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oncolytic Viruses | 2 | 2024 | 327 | 0.850 |
Why?
|
Evoked Potentials, Motor | 2 | 2021 | 454 | 0.760 |
Why?
|
Ki-67 Antigen | 2 | 2021 | 644 | 0.750 |
Why?
|
Oncolytic Virotherapy | 2 | 2024 | 498 | 0.750 |
Why?
|
Pyramidal Tracts | 1 | 2020 | 255 | 0.650 |
Why?
|
Immunoglobulins | 1 | 2021 | 881 | 0.600 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2019 | 234 | 0.570 |
Why?
|
Cranial Fossa, Middle | 1 | 2016 | 28 | 0.560 |
Why?
|
Brain Neoplasms | 5 | 2023 | 8856 | 0.560 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2021 | 1018 | 0.550 |
Why?
|
Glioma | 3 | 2023 | 3401 | 0.550 |
Why?
|
Central Nervous System Neoplasms | 2 | 2023 | 895 | 0.550 |
Why?
|
Lymphoma | 2 | 2023 | 1875 | 0.520 |
Why?
|
Electric Stimulation | 1 | 2020 | 1760 | 0.520 |
Why?
|
Cell Dedifferentiation | 1 | 2016 | 135 | 0.520 |
Why?
|
Bethanechol | 1 | 2014 | 13 | 0.500 |
Why?
|
Malacoplakia | 1 | 2014 | 15 | 0.490 |
Why?
|
Central Nervous System | 2 | 2023 | 1358 | 0.480 |
Why?
|
Motor Cortex | 1 | 2020 | 986 | 0.440 |
Why?
|
Skull Base Neoplasms | 1 | 2016 | 284 | 0.420 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2021 | 1433 | 0.390 |
Why?
|
Ascorbic Acid | 1 | 2014 | 650 | 0.380 |
Why?
|
Meningioma | 3 | 2016 | 1209 | 0.360 |
Why?
|
Meningeal Neoplasms | 2 | 2016 | 1241 | 0.300 |
Why?
|
Cerebral Hemorrhage | 1 | 2019 | 2647 | 0.300 |
Why?
|
Sarcoma | 1 | 2019 | 1898 | 0.290 |
Why?
|
Neural Inhibition | 2 | 2021 | 598 | 0.280 |
Why?
|
Macrophages | 1 | 2021 | 5651 | 0.270 |
Why?
|
Glioblastoma | 1 | 2021 | 3480 | 0.260 |
Why?
|
Membrane Proteins | 1 | 2021 | 7880 | 0.230 |
Why?
|
Pinealoma | 1 | 2023 | 54 | 0.220 |
Why?
|
Pineal Gland | 1 | 2023 | 166 | 0.210 |
Why?
|
Medetomidine | 1 | 2020 | 3 | 0.190 |
Why?
|
Xylazine | 1 | 2020 | 10 | 0.190 |
Why?
|
Butorphanol | 1 | 2020 | 12 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9239 | 0.190 |
Why?
|
ROC Curve | 2 | 2021 | 3527 | 0.180 |
Why?
|
Long-Term Potentiation | 1 | 2021 | 293 | 0.170 |
Why?
|
Simplexvirus | 1 | 2023 | 803 | 0.170 |
Why?
|
Ethmoid Sinus | 1 | 2019 | 58 | 0.170 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 424 | 0.170 |
Why?
|
Midazolam | 1 | 2020 | 270 | 0.160 |
Why?
|
Methotrexate | 2 | 2023 | 1726 | 0.150 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2021 | 3758 | 0.150 |
Why?
|
Diffusion Tensor Imaging | 2 | 2021 | 2305 | 0.150 |
Why?
|
Brain Ischemia | 2 | 2022 | 3264 | 0.140 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7172 | 0.130 |
Why?
|
Lactic Acid | 1 | 2020 | 1131 | 0.120 |
Why?
|
Ketamine | 1 | 2020 | 501 | 0.120 |
Why?
|
Rats | 2 | 2021 | 24250 | 0.120 |
Why?
|
Muscarinic Agonists | 1 | 2014 | 87 | 0.120 |
Why?
|
Heat Stroke | 1 | 2014 | 31 | 0.120 |
Why?
|
Oculomotor Nerve Diseases | 1 | 2014 | 48 | 0.120 |
Why?
|
Neoplasms | 1 | 2023 | 21675 | 0.120 |
Why?
|
Models, Animal | 1 | 2020 | 2172 | 0.120 |
Why?
|
Extreme Heat | 1 | 2014 | 37 | 0.110 |
Why?
|
Hydrocephalus | 1 | 2020 | 748 | 0.110 |
Why?
|
Inclusion Bodies | 1 | 2014 | 279 | 0.110 |
Why?
|
Spin Labels | 1 | 2014 | 332 | 0.110 |
Why?
|
Hypnotics and Sedatives | 1 | 2020 | 1161 | 0.110 |
Why?
|
Skull Base | 1 | 2014 | 305 | 0.100 |
Why?
|
Aged | 9 | 2023 | 163178 | 0.090 |
Why?
|
Aneurysm, Ruptured | 1 | 2014 | 452 | 0.080 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3583 | 0.080 |
Why?
|
Endovascular Procedures | 1 | 2022 | 1980 | 0.080 |
Why?
|
Immunotherapy | 1 | 2023 | 4437 | 0.070 |
Why?
|
Cerebellar Neoplasms | 1 | 1992 | 587 | 0.070 |
Why?
|
Middle Aged | 9 | 2023 | 213241 | 0.070 |
Why?
|
Brain | 4 | 2023 | 26345 | 0.070 |
Why?
|
Humans | 15 | 2023 | 743811 | 0.070 |
Why?
|
Vitamins | 1 | 2014 | 1622 | 0.070 |
Why?
|
Calcinosis | 1 | 2014 | 1495 | 0.060 |
Why?
|
Intracranial Aneurysm | 1 | 2014 | 1197 | 0.060 |
Why?
|
Male | 9 | 2023 | 349776 | 0.060 |
Why?
|
Prognosis | 2 | 2022 | 29052 | 0.060 |
Why?
|
Burns | 1 | 2014 | 1815 | 0.050 |
Why?
|
Female | 10 | 2023 | 380020 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16361 | 0.050 |
Why?
|
Cytarabine | 1 | 2023 | 692 | 0.050 |
Why?
|
Vincristine | 1 | 2023 | 1039 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2023 | 629 | 0.050 |
Why?
|
Skin | 1 | 2014 | 4372 | 0.050 |
Why?
|
Adenoviridae | 1 | 2024 | 1100 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2022 | 426 | 0.040 |
Why?
|
Stroke | 1 | 2022 | 9975 | 0.040 |
Why?
|
Animals | 2 | 2021 | 168660 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1676 | 0.040 |
Why?
|
Thrombectomy | 1 | 2022 | 680 | 0.040 |
Why?
|
Adult | 4 | 2021 | 213889 | 0.030 |
Why?
|
Child | 2 | 2023 | 77637 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2024 | 1978 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 35409 | 0.030 |
Why?
|
Cerebellopontine Angle | 1 | 1992 | 55 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2023 | 77410 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16674 | 0.020 |
Why?
|
Adolescent | 1 | 2014 | 85729 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2023 | 63042 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15067 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11524 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 40545 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2014 | 57744 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 53250 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40038 | 0.010 |
Why?
|
Risk Factors | 2 | 2020 | 72252 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1992 | 20121 | 0.010 |
Why?
|
Sex Factors | 1 | 1989 | 10394 | 0.000 |
Why?
|
Age Factors | 1 | 1989 | 18355 | 0.000 |
Why?
|
Concepts
(107)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_